Invesco S&P 500 High Div Low Volatility ETF vs Tilray Brands Inc — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $48.8 (market cap $3.14B), while Tilray Brands Inc trades at $3.53 (market cap $530.54M). The key difference: Invesco S&P 500 High Div Low Volatility ETF is far larger — about 5.9× Tilray Brands Inc's market cap, and Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 High Div Low Volatility ETF for 125 Days and Tilray Brands Inc for 31 Days on average.
| SPHD | TLRY | |
|---|---|---|
Market Cap | $3.14B | $530.54M |
Volume | 1,461,349 | 9,099,075 |
52-Week High | $53.55 | $21.00 |
52-Week Low | $46.96 | $3.57 |
Typical Hold Time | 125 Days | 31 Days |
Sector | — | Health |
Enterprise Value | — | $684.46M |
Signals from Pluang's Aura AI — not financial advice
SPHD trades at $48.19, down 0.58% on the day, with a bearish technical signal driven by moving averages. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering monthly income but facing criticism for weaker total returns compared to peers like SCHD. Recent dividends of $0.20 and $0.21 were declared for 2026, emphasizing its income-oriented strategy.
Outlook is cautious due to underperformance risks and lack of quality filters in stock selection. Opportunities include reliable monthly dividends for retirees, but risks involve yield traps and market volatility. Investors should weigh income needs against growth potential.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →